Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients
Lichen planopilaris and frontal fibrosing alopecia are common variants of primary lymphocytic cicatricial alopecia, leading to permanent hair loss. Despite widespread use of various systemic treatments, evidence-based guidelines for these conditions are lacking. This study investigates the effective...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Journals Sweden
2025-04-01
|
| Series: | Acta Dermato-Venereologica |
| Subjects: | |
| Online Access: | https://medicaljournalssweden.se/actadv/article/view/42465 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850176835749412864 |
|---|---|
| author | Mathias Willaert Tristan van Dongen Petra Dikrama Tamar Nijsten DirkJan Hijnen Rick Waalboer-Spuij |
| author_facet | Mathias Willaert Tristan van Dongen Petra Dikrama Tamar Nijsten DirkJan Hijnen Rick Waalboer-Spuij |
| author_sort | Mathias Willaert |
| collection | DOAJ |
| description | Lichen planopilaris and frontal fibrosing alopecia are common variants of primary lymphocytic cicatricial alopecia, leading to permanent hair loss. Despite widespread use of various systemic treatments, evidence-based guidelines for these conditions are lacking. This study investigates the effectiveness of systemic treatment options in patients with lichen planopilaris and frontal fibrosing alopecia through a retrospective cohort analysis. Medical records of patients treated at the Department of Dermatology between 2016 and 2022 at the Erasmus University Medical Center Rotterdam, the Netherlands were reviewed. Of 315 patients identified (161 lichen planopilaris and 154 frontal fibrosing alopecia), the majority were female (90.5%), with hydroxychloroquine being the most common systemic treatment, used by 65.2% of lichen planopilaris and 57.8% of frontal fibrosing alopecia patients. Methotrexate had the highest response rate for lichen planopilaris (79.2%), while retinoids showed the highest response for frontal fibrosing alopecia (73.9%). However, treatments with cyclosporine A and retinoids had higher discontinuation rates due to side effects. This study suggests methotrexate and cyclosporine A may be most effective for lichen planopilaris, and cyclosporine A and retinoids for frontal fibrosing alopecia, though side effects remain a concern. Limitations include the retrospective design and the absence of standardized outcomes. Prospective studies are recommended to validate these findings.
|
| format | Article |
| id | doaj-art-4be542a0476849c28ffcd06b0318ffb0 |
| institution | OA Journals |
| issn | 0001-5555 1651-2057 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Medical Journals Sweden |
| record_format | Article |
| series | Acta Dermato-Venereologica |
| spelling | doaj-art-4be542a0476849c28ffcd06b0318ffb02025-08-20T02:19:11ZengMedical Journals SwedenActa Dermato-Venereologica0001-55551651-20572025-04-0110510.2340/actadv.v105.42465Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 PatientsMathias Willaert0Tristan van Dongen1Petra Dikrama2Tamar Nijsten3DirkJan Hijnen4Rick Waalboer-Spuij5Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the NetherlandsDepartment of Dermatology, Spaarne Gasthuis, Haarlem, the NetherlandsDepartment of Dermatology, Erasmus MC University Medical Center, Rotterdam, the NetherlandsDepartment of Dermatology, Erasmus MC University Medical Center, Rotterdam, the NetherlandsDepartment of Dermatology, Radboud University Medical Center, Nijmegen, the NetherlandsDepartment of Dermatology, Erasmus MC University Medical Center, Rotterdam, the NetherlandsLichen planopilaris and frontal fibrosing alopecia are common variants of primary lymphocytic cicatricial alopecia, leading to permanent hair loss. Despite widespread use of various systemic treatments, evidence-based guidelines for these conditions are lacking. This study investigates the effectiveness of systemic treatment options in patients with lichen planopilaris and frontal fibrosing alopecia through a retrospective cohort analysis. Medical records of patients treated at the Department of Dermatology between 2016 and 2022 at the Erasmus University Medical Center Rotterdam, the Netherlands were reviewed. Of 315 patients identified (161 lichen planopilaris and 154 frontal fibrosing alopecia), the majority were female (90.5%), with hydroxychloroquine being the most common systemic treatment, used by 65.2% of lichen planopilaris and 57.8% of frontal fibrosing alopecia patients. Methotrexate had the highest response rate for lichen planopilaris (79.2%), while retinoids showed the highest response for frontal fibrosing alopecia (73.9%). However, treatments with cyclosporine A and retinoids had higher discontinuation rates due to side effects. This study suggests methotrexate and cyclosporine A may be most effective for lichen planopilaris, and cyclosporine A and retinoids for frontal fibrosing alopecia, though side effects remain a concern. Limitations include the retrospective design and the absence of standardized outcomes. Prospective studies are recommended to validate these findings. https://medicaljournalssweden.se/actadv/article/view/42465cicatricial alopecialichen planopilarisfrontal fibrosing alopeciainflammatory hair disorderhair losssystemic treatment |
| spellingShingle | Mathias Willaert Tristan van Dongen Petra Dikrama Tamar Nijsten DirkJan Hijnen Rick Waalboer-Spuij Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients Acta Dermato-Venereologica cicatricial alopecia lichen planopilaris frontal fibrosing alopecia inflammatory hair disorder hair loss systemic treatment |
| title | Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients |
| title_full | Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients |
| title_fullStr | Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients |
| title_full_unstemmed | Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients |
| title_short | Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients |
| title_sort | systemic treatments for lichen planopilaris and frontal fibrosing alopecia a retrospective study of 315 patients |
| topic | cicatricial alopecia lichen planopilaris frontal fibrosing alopecia inflammatory hair disorder hair loss systemic treatment |
| url | https://medicaljournalssweden.se/actadv/article/view/42465 |
| work_keys_str_mv | AT mathiaswillaert systemictreatmentsforlichenplanopilarisandfrontalfibrosingalopeciaaretrospectivestudyof315patients AT tristanvandongen systemictreatmentsforlichenplanopilarisandfrontalfibrosingalopeciaaretrospectivestudyof315patients AT petradikrama systemictreatmentsforlichenplanopilarisandfrontalfibrosingalopeciaaretrospectivestudyof315patients AT tamarnijsten systemictreatmentsforlichenplanopilarisandfrontalfibrosingalopeciaaretrospectivestudyof315patients AT dirkjanhijnen systemictreatmentsforlichenplanopilarisandfrontalfibrosingalopeciaaretrospectivestudyof315patients AT rickwaalboerspuij systemictreatmentsforlichenplanopilarisandfrontalfibrosingalopeciaaretrospectivestudyof315patients |